Evaluación económica del uso de voriconazol versus anfotericina B en el tratamiento de la aspergilosis invasiva

Voriconazole is more efficient than amphotericin B deoxycholate in the treatment of invasive aspergillosis, (thus) resulting in healthcare resources saving due to better clinical results with lower associated costs.